Leadership
February 02, 2022
RoslinCT Boston (former Lykan Bioscience) Welcomes Jay Blackington as Head of People and Culture
Cell Therapy, Investment, Partnerships
January 11, 2022
GHO Capital invests in RoslinCT, a leading cell therapy CDMO
Facilities, Site Expansion
February 05, 2021